SUPN compared with LGND: revenue, margins and what each company keeps, and the suppliers and customers both name

SUPNSupernus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

LGNDLigand Pharmaceuticals Inc

Mkt capRevenueRevenue

Compare

SUPNSupernus Pharmaceuticals, Inc.

LGNDLigand Pharmaceuticals Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Co-movers

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Co-movers

daily closesMethod ›

Moved together

SUPNwithLGND

Uncorrelated: r 0.23 · 499D.

Shared co-movers1with SUPNwith LGND

INDVIndivior Pharmaceuticals, Inc.r 0.43r 0.40

SUPN, solidLGND, hatchedr = correlationBar = r to r 0.75Order: weaker of A and BSource: daily closes

SUPNSupernus Pharmaceuticals, Inc.

26.76· pre 26.90· delayed

Mkt cap$3.2BRevenue$356MQ3 FY26Revenue$719MFY25

LGNDLigand Pharmaceuticals Inc

300.62· pre 298.00· delayed

Pre-marketNov 5 '26delayed

Mkt cap$6.0BRevenue$79MQ3 FY26Revenue$268MFY25

Compare

Pre-marketNov 5 '26delayed

SUPNSupernus Pharmaceuticals, Inc.

LGNDLigand Pharmaceuticals Inc

26.76pre 26.90delayed

Price

300.62pre 298.00delayed

$3.2B

Mkt cap

$6.0B

Q3 FY26$356M

Revenue

$79MQ3 FY26

FY25$719M

Revenue

$268MFY25

SUPN26.76vsLGND300.62Pre-marketNov 5 '26delayed